Session VII: Colorectal Cancer II
FULL ABSTRACTS AVAILABLE SATURDAY JULY 4
Late-Breaking Abstract-6: Safety, feasibility, tolerability, and preliminary efficacy of perioperative systemic therapy for resectable colorectal peritoneal metastases: pilot phase of a randomised trial (CAIRO6)
Servier Satellite Symposium:
Short Oral-28: A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer (mCRC)
Short Oral-29: Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: a nationwide comparative study
Short Oral-30: Adjuvant systemic chemotherapy versus active surveillance following upfront resection of isolated synchronous colorectal peritoneal metastases: propensity score-matched analysis of a nationwide registry.